I agree - the safety profile of Trof once approved will (should) form a basis of new approvals so a phase 3 you would think would suffice fir new indications.
Ann: Investor presentation, 8 August 2022, page-16
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.31 |
Change
-0.340(2.49%) |
Mkt cap ! $1.719B | |||
| Open | High | Low | Value | Volume |
| $13.68 | $13.68 | $13.24 | $1.788M | 133.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 602 | $13.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.33 | 1032 | 10 |
View Market Depth
| Last trade - 13.02pm 18/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |